Curanex Pharmaceuticals (CURX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.62, -4.35% vs the prior close of $4.83.
- Volume 10.32K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CURX slides 4.3% to $4.62. Closed at $4.62, -4.35% vs the prior close of $4.83. Day range $4.61β$4.95, opened at $4.85.
CURX daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β CURX slides 4.3% to $4.62
- Closed at $4.62, -4.35% vs the prior close of $4.83. Day range $4.61β$4.95, opened at $4.85.
- Volume was 10.32K shares, 0.4x its 50-day average of 24.44K β lighter than usual.
- Price is -0.3% vs its 50-day average ($4.64) and -26.5% vs its 200-day average ($6.29).
- 52-week range $3.58β$16.94; today's close sits at 8% of that range, 72.7% below the 52-week high.
Oct 15, 2026 β CURX dips 2.6% to $4.83
- Closed at $4.83, -2.62% vs the prior close of $4.96. Day range $4.75β$5.19, opened at $4.87.
- Volume was 16.00K shares, 0.7x its 50-day average of 24.27K.
- Price is +4.5% vs its 50-day average ($4.62) and -23.3% vs its 200-day average ($6.30).
- 52-week range $3.58β$16.94; today's close sits at 9% of that range, 71.5% below the 52-week high.
Oct 14, 2026 β CURX rises 1.6% to $4.96
- Closed at $4.96, +1.64% vs the prior close of $4.88. Day range $4.31β$5.00, opened at $4.40.
- Volume was 9.10K shares, 0.4x its 50-day average of 24.25K β lighter than usual.
- Price is +7.7% vs its 50-day average ($4.60) and -21.4% vs its 200-day average ($6.31).
- 52-week range $3.58β$16.94; today's close sits at 10% of that range, 70.7% below the 52-week high.
Oct 13, 2026 β CURX ends flat (+0.0%) to $4.88
- Closed at $4.88, +0.00% vs the prior close of $4.88. Day range $4.88β$4.88, opened at $4.88.
- Price is +6.4% vs its 50-day average ($4.59) and -22.8% vs its 200-day average ($6.32).
- 52-week range $3.58β$16.94; today's close sits at 10% of that range, 71.2% below the 52-week high.
Oct 12, 2026 β CURX slides 8.1% to $4.88
- Closed at $4.88, -8.10% vs the prior close of $5.31. Day range $4.88β$5.17, opened at $5.04.
- Volume was 7.90K shares, 0.3x its 50-day average of 24.79K β lighter than usual.
- Price is +6.7% vs its 50-day average ($4.58) and -23.0% vs its 200-day average ($6.34).
- 52-week range $3.58β$16.94; today's close sits at 10% of that range, 71.2% below the 52-week high.
Oct 9, 2026 β CURX jumps 11.6% to $5.31, a 1-month high
- Closed at $5.31, +11.55% vs the prior close of $4.76. Day range $4.61β$5.31, opened at $4.61.
- Volume was 15.70K shares, 0.6x its 50-day average of 24.49K.
- Price is +16.5% vs its 50-day average ($4.56) and -16.4% vs its 200-day average ($6.35).
- 52-week range $3.58β$16.94; today's close sits at 13% of that range, 68.7% below the 52-week high.
Oct 8, 2026 β CURX ends flat (-0.2%) to $4.76
- Closed at $4.76, -0.21% vs the prior close of $4.77. Day range $4.51β$4.90, opened at $4.75.
- Volume was 14.40K shares, 0.6x its 50-day average of 24.24K β lighter than usual.
- Price is +5.1% vs its 50-day average ($4.53) and -25.2% vs its 200-day average ($6.37).
- 52-week range $3.58β$16.94; today's close sits at 9% of that range, 71.9% below the 52-week high.
Oct 7, 2026 β CURX slides 4.4% to $4.77 on 4.6x normal volume
- Closed at $4.77, -4.41% vs the prior close of $4.99. Day range $4.45β$5.15, opened at $4.79.
- Volume was 102.00K shares, 4.6x its 50-day average of 22.25K β unusually heavy trading.
- Price is +5.7% vs its 50-day average ($4.51) and -25.2% vs its 200-day average ($6.38).
- 52-week range $3.58β$16.94; today's close sits at 9% of that range, 71.8% below the 52-week high.
Oct 6, 2026 β CURX rises 0.6% to $4.99 on 2.0x normal volume
- Closed at $4.99, +0.60% vs the prior close of $4.96. Day range $4.88β$5.29, opened at $5.09.
- Volume was 42.30K shares, 2.0x its 50-day average of 21.52K β unusually heavy trading.
- Price is +11.0% vs its 50-day average ($4.50) and -22.0% vs its 200-day average ($6.40).
- 52-week range $3.58β$16.94; today's close sits at 11% of that range, 70.5% below the 52-week high.
Oct 5, 2026 β CURX jumps 5.1% to $4.96 on 4.4x normal volume
- Closed at $4.96, +5.08% vs the prior close of $4.72. Day range $4.32β$5.04, opened at $4.32.
- Volume was 87.40K shares, 4.4x its 50-day average of 19.83K β unusually heavy trading.
- Price is +11.0% vs its 50-day average ($4.47) and -22.6% vs its 200-day average ($6.41).
- 52-week range $3.58β$16.94; today's close sits at 10% of that range, 70.7% below the 52-week high.
Oct 2, 2026 β CURX slides 5.0% to $4.72
- Closed at $4.72, -5.03% vs the prior close of $4.97. Day range $4.59β$5.10, opened at $4.70.
- Volume was 2.70K shares, 0.1x its 50-day average of 19.86K β lighter than usual.
- Price is +6.2% vs its 50-day average ($4.45) and -26.5% vs its 200-day average ($6.43).
- 52-week range $3.58β$16.94; today's close sits at 9% of that range, 72.1% below the 52-week high.
CURX latest news & SEC filings
Every SEC filing by or about CURX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 4, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Aug 17, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.03 β Change to shareholder rights.
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.29M (prior year -$60.35K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year $0.00)
Jul 21, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 29, 2026 Β· Form DEF 14C β DEF 14C filing
DEF 14C filing
Things to know before you trade CURX
- How much it moves: over the last 20 sessions the average daily move was 3.42% (largest 11.6%). That is a volatile stock.
- Liquidity: about 22.90K shares (β$105.80K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.62 vs a range of $3.58β$16.94 (8% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:20 on Aug 20, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 4, 2026; 8-K Aug 17, 2026; 10-Q Aug 14, 2026.
- Share count: 31.36M shares outstanding (Aug 14, 2026), +13.0% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
CURX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.85 | 4.95 | 4.61 | 4.62 | 10.32K |
| Oct 15, 2026 | 4.87 | 5.19 | 4.75 | 4.83 | 16.00K |
| Oct 14, 2026 | 4.40 | 5.00 | 4.31 | 4.96 | 9.10K |
| Oct 13, 2026 | 4.88 | 4.88 | 4.88 | 4.88 | 0 |
| Oct 12, 2026 | 5.04 | 5.17 | 4.88 | 4.88 | 7.90K |
| Oct 9, 2026 | 4.61 | 5.31 | 4.61 | 5.31 | 15.70K |
| Oct 8, 2026 | 4.75 | 4.90 | 4.51 | 4.76 | 14.40K |
| Oct 7, 2026 | 4.79 | 5.15 | 4.45 | 4.77 | 102.00K |
| Oct 6, 2026 | 5.09 | 5.29 | 4.88 | 4.99 | 42.30K |
| Oct 5, 2026 | 4.32 | 5.04 | 4.32 | 4.96 | 87.40K |
| Oct 2, 2026 | 4.70 | 5.10 | 4.59 | 4.72 | 2.70K |
| Oct 1, 2026 | 4.93 | 5.05 | 4.75 | 4.97 | 8.00K |
| Sep 30, 2026 | 4.99 | 5.03 | 4.99 | 5.03 | 1.20K |
| Sep 29, 2026 | 5.08 | 5.08 | 4.97 | 4.97 | 1.00K |
| Sep 28, 2026 | 4.81 | 5.27 | 4.44 | 5.03 | 20.50K |
| Sep 25, 2026 | 4.41 | 5.00 | 4.40 | 4.74 | 71.30K |
| Sep 24, 2026 | 4.45 | 4.50 | 4.30 | 4.45 | 3.40K |
| Sep 23, 2026 | 4.44 | 4.47 | 4.40 | 4.47 | 4.30K |
| Sep 22, 2026 | 4.80 | 4.88 | 4.40 | 4.58 | 24.10K |
| Sep 21, 2026 | 4.29 | 4.50 | 4.05 | 4.37 | 16.40K |
About Curanex Pharmaceuticals
Curanex Pharmaceuticals (CURX) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in JERICHO, NY. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 2025942.
CURX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CURX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-4.23M | -0.17 | $-10.48M |
| Dec 31, 2024 | β | $-361.51K | -0.03 | $-555.58K |
Latest balance sheet: total assets $5.07M, total liabilities $286.25K, cash $2.94M (as of Jun 30, 2026).
CURX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CURX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.